Atlas Trials

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Clinical trial NCT05034822 · COMPLETED

Trial details

NCT number
NCT05034822
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2021-12-16
Primary completion
2023-08-07
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.